Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: SOBI: EMA Validates Indication Extension Application For Tryngolza (Olezarsen)

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    30/03/2026 07:06
    March 30 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

EMA VALIDATES INDICATION EXTENSION APPLICATION FOR TRYNGOLZA (OLEZARSEN) FOR THE TREATMENT OF SEVERE HYPERTRIGLYCERIDEMIA (SHTG)

Source text: source

Further company coverage: SOBIV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news